Compare IART & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | KBDC |
|---|---|---|
| Founded | 1989 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.7M | 1.0B |
| IPO Year | 1995 | N/A |
| Metric | IART | KBDC |
|---|---|---|
| Price | $11.13 | $14.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $15.00 | ★ $15.80 |
| AVG Volume (30 Days) | ★ 697.1K | 294.1K |
| Earning Date | 02-24-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 13.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,642,966,000.00 | N/A |
| Revenue This Year | $3.26 | $193.84 |
| Revenue Next Year | $2.71 | $9.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $10.70 | $13.06 |
| 52 Week High | $27.13 | $17.99 |
| Indicator | IART | KBDC |
|---|---|---|
| Relative Strength Index (RSI) | 37.37 | 38.52 |
| Support Level | $10.70 | $14.14 |
| Resistance Level | $12.08 | $14.63 |
| Average True Range (ATR) | 0.55 | 0.32 |
| MACD | -0.14 | -0.06 |
| Stochastic Oscillator | 15.72 | 22.34 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.